Abeona Therapeutics Inc. (ABEO)
$5.91
$-0.07
(-1.17%)
As on 02-Sep-2026 14:36EDT
Market cap
$339 Mln
Revenue (TTM)
$26 Mln
P/E Ratio
--
P/B Ratio
2.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.4 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
3.8
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-1.1
-
Face value
--
-
Shares outstanding
57,184,017
10 Years Aggregate
CFO
$-331.09 Mln
EBITDA
$-372.52 Mln
Net Profit
$-486.80 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Abeona Therapeutics (ABEO)
| 12.1 | -7.9 | 5.0 | -13.5 | 12.1 | -28.8 | -25.2 |
|
BSE Sensex
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Abeona Therapeutics (ABEO)
| -5.4 | 11.1 | 62.7 | -63.8 | -78.3 | -52.0 | -54.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Abeona Therapeutics (ABEO)
|
5.9 | 338.5 | 25.5 | -62.9 | -293.8 | -43.8 | -- | 2.7 |
| 83.9 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 265.6 | 16,261.1 | 1,054.4 | 755.9 | 5.7 | -- | 19 | 9.8 | |
| 71.2 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 58.4 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 109.2 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 366.5 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 543.3 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 592.3 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 354.6 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 |
Shareholding Pattern
View DetailsAbout Abeona Therapeutics (ABEO)
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients... with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio. Read more
-
President, CEO & Director
Dr. Vishwas Seshadri M.B.A., Ph.D.
-
President, CEO & Director
Dr. Vishwas Seshadri M.B.A., Ph.D.
-
Headquarters
Cleveland, OH
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Abeona Therapeutics (ABEO)
What is the current share price of Abeona Therapeutics Inc (ABEO) Today?
The share price of Abeona Therapeutics Inc (ABEO) is $5.91 (NASDAQ) as of 02-Sep-2026 14:36 EDT. Abeona Therapeutics Inc (ABEO) has given a return of 12.15% in the last 3 years.
What is the current PB & PE ratio of Abeona Therapeutics Inc (ABEO)?
Since, TTM earnings of Abeona Therapeutics Inc (ABEO) is negative, P/E ratio is not available.
The P/B ratio of Abeona Therapeutics Inc (ABEO) is 2.70 times as on 28-Aug-2026, a 48 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
4.90 |
2.19 |
2024 |
-3.59 |
5.19 |
2023 |
-2.36 |
8.64 |
2022 |
-0.55 |
0.82 |
2021 |
-0.02 |
0.03 |
What is the 52 Week High and Low of Abeona Therapeutics Inc (ABEO)?
The 52-week high and low of Abeona Therapeutics Inc (ABEO) are Rs 7.65 and Rs 4.00 as of 03-Sep-2026.
What is the market cap of Abeona Therapeutics Inc (ABEO)?
Abeona Therapeutics Inc (ABEO) has a market capitalisation of $ 339 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Abeona Therapeutics Inc (ABEO)?
Before investing in Abeona Therapeutics Inc (ABEO), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.